Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 50Neoplasm Metastasis 13Breast Neoplasms 9Carcinoma, Renal Cell 6Pain 5Osteoporosis 5Neoplasms 3Multiple Myeloma 3Kidney Neoplasms 3Lung Neoplasms 2Bone Neoplasms 2Bone Diseases, Metabolic 2Urologic Neoplasms 1Renal Insufficiency 1Insulin Resistance 1Clear-cell metastatic renal cell carcinoma 1Carcinoma, Non-Small-Cell Lung 1Bone Diseases 1

Interventions

Pioglitazone 3Zoledronic Acid 1Tablets 1Health Planning Guidelines 1Exercise 1Endurance Training 1Androgen Antagonists 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Insulin Resistance × Zoledronic Acid × Genitourinary × Clear all
NCT01006395 2019-07-05

Prevention of Micro-architectural Bone Decay in Males With Non-metastatic Prostate Cancer Receiving Androgen Deprivation Therapy (ADT)

Austin Health

Phase 2/3 Completed
64 enrolled
Genitourinary

Insulin Resistance, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡